ZARBO, Ignazio Roberto
 Distribuzione geografica
Continente #
NA - Nord America 2.839
AS - Asia 1.555
SA - Sud America 1.164
EU - Europa 903
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 68
OC - Oceania 2
Totale 6.611
Nazione #
US - Stati Uniti d'America 2.753
BR - Brasile 1.034
SG - Singapore 646
CN - Cina 379
IT - Italia 260
VN - Vietnam 153
UA - Ucraina 139
DE - Germania 131
HK - Hong Kong 123
FR - Francia 72
GB - Regno Unito 61
SE - Svezia 46
AR - Argentina 39
FI - Finlandia 37
IQ - Iraq 37
BD - Bangladesh 35
MX - Messico 33
ZA - Sudafrica 32
CA - Canada 29
RU - Federazione Russa 28
IN - India 26
TR - Turchia 25
EC - Ecuador 23
PK - Pakistan 23
VE - Venezuela 22
CZ - Repubblica Ceca 21
NL - Olanda 20
ES - Italia 19
PL - Polonia 17
TN - Tunisia 16
UZ - Uzbekistan 15
CO - Colombia 14
JP - Giappone 12
PY - Paraguay 12
PE - Perù 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
BE - Belgio 9
ID - Indonesia 9
LT - Lituania 9
MA - Marocco 9
JO - Giordania 7
SA - Arabia Saudita 7
DO - Repubblica Dominicana 6
AZ - Azerbaigian 5
CL - Cile 5
HN - Honduras 5
KR - Corea 5
PH - Filippine 5
BW - Botswana 4
IE - Irlanda 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
RO - Romania 4
SV - El Salvador 4
AO - Angola 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
EE - Estonia 3
EU - Europa 3
KG - Kirghizistan 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
EG - Egitto 2
IL - Israele 2
KW - Kuwait 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AM - Armenia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MV - Maldive 1
PR - Porto Rico 1
QA - Qatar 1
RE - Reunion 1
SC - Seychelles 1
SR - Suriname 1
Totale 6.545
Città #
Dallas 688
Singapore 345
San Jose 278
Ashburn 226
Chandler 201
Council Bluffs 127
Hong Kong 120
Beijing 101
Santa Clara 92
Jacksonville 81
São Paulo 77
Columbus 65
Princeton 58
Munich 50
Lauterbourg 49
New York 49
Ho Chi Minh City 46
Shanghai 46
Los Angeles 42
Rio de Janeiro 36
Milan 33
Hanoi 31
Belo Horizonte 29
Nanjing 28
Dearborn 25
Sassari 24
Helsinki 21
Ann Arbor 20
Baghdad 20
Wilmington 20
Brasília 19
Brno 17
Johannesburg 17
London 17
Porto Alegre 17
Campinas 16
Nanchang 15
Orem 15
Warsaw 14
Brooklyn 13
Curitiba 13
Fortaleza 13
Salvador 13
Guarulhos 12
Miano 12
Rome 12
Tashkent 12
Boardman 11
Denver 11
Phoenix 11
Tokyo 11
Buffalo 10
Cagliari 10
Da Nang 10
Frankfurt am Main 10
Hebei 10
Mountain View 10
Washington 10
Amsterdam 9
Chennai 9
Haiphong 9
Joinville 9
Lima 9
Nuremberg 9
Tunis 9
Atlanta 8
Boston 8
Brussels 8
Changsha 8
Istanbul 8
Jiaxing 8
Ribeirão Preto 8
Ribeirão das Neves 8
San Francisco 8
Santo André 8
Seattle 8
Shenyang 8
Amman 7
Canoas 7
Chicago 7
Düsseldorf 7
Guayaquil 7
Houston 7
Poplar 7
Stockholm 7
São Gonçalo 7
Tianjin 7
Toronto 7
Volta Redonda 7
Asunción 6
Carrboro 6
Caruaru 6
Manchester 6
Mexico City 6
Montreal 6
Quito 6
The Dalles 6
Vienna 6
Baku 5
Bauru 5
Totale 3.696
Nome #
A rare case of lupus-like syndrome during treatment with interferon β-1a. 233
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 206
Herv-k modulates the immune response in als patients 197
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 166
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 163
Corpus callosum volumetrics and clinical progression in early multiple sclerosis 159
Antihuman Endogenous Retrovirus Immune Response and Adaptive Dysfunction in Autism 156
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 156
Treadmill-virtual reality combined training program to improve gait in multiple sclerosis individuals 152
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 152
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 150
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 150
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 147
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis 146
Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children 141
Proteomic analysis of CSF in multiple sclerosis patients and controls: a study in Sardinian population 141
First evidence of the cross-training effect in multiple sclerosis 140
Signs and symptoms of COVID-19 in patients with multiple sclerosis 135
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 135
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 134
ADEM o sclerosi Multipla: la comunicazione di una diagnosi difficile 134
Inflammation, infectious triggers, and Parkinson's disease 131
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series. 130
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 130
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 127
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 122
A six-week intensive treadmill training improves walking ability in MS patients with moderate disability 120
Intensive treadmill training improves gait in moderately impaired multiple sclerosis individuals 120
Virtual reality-treadmill training to improve gait in people with multiple sclerosis 118
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 116
Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring 114
Influence of psychological and social factors on self perceived health-related quality of life in patients with multiple sclerosis 113
Natalizumab as treatment option of refractory epilepsy in multiple sclerosis. 111
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 111
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 108
RNA-binding proteins in autoimmunity: From genetics to molecular biology 106
Paresi del IX e X nervi cranici da ematoma parietale post-traumatico della carotide interna in paziente con crisi convulsiva 103
Sclerosi combinata del midollo, neuropatia ottica e deterioramento cognitivo post-resezione intestinale. Ruolo patogenetico della carenza di oligoelementi? 103
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 98
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 98
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 97
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 96
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 95
HERV-W/MSRV in the CSF significantly predicts the secondary progressive MS course upon 10-years follow-up 91
The Impact of Autistic Traits on Quality of Life and Symptom Severity in Multiple Sclerosis Patients: A Cross-Sectional Study 90
Multiple Sclerosis Progression and Relapse Activity in Children 88
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 87
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study 87
Mycobacterium avium subspecies paratuberculosis (MAP) infection, and its impact on gut microbiome of individuals with multiple sclerosis 86
On a 5-year-old girl with multiple sclerosis treated with natalizumab 83
Identification of hsa_circ_0018905 as a New Potential Biomarker for Multiple Sclerosis 78
Rasagiline Withdrawal Syndrome in Parkinson’s Disease 77
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 66
Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study 18
Totale 6.611
Categoria #
all - tutte 27.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022140 0 0 0 1 2 2 3 23 13 27 12 57
2022/2023366 29 48 6 61 43 47 1 34 56 20 12 9
2023/2024173 16 17 8 6 36 18 1 14 0 7 15 35
2024/20252.034 77 21 136 65 47 69 104 453 620 317 90 35
2025/20262.653 89 597 310 439 286 162 347 71 123 146 58 25
2026/2027754 59 190 219 286 0 0 0 0 0 0 0 0
Totale 6.611